Literature DB >> 33713587

Characteristics of infants or children presenting to outpatient bronchopulmonary dysplasia clinics in the United States.

Joseph M Collaco1, Amit Agarwal2, Eric D Austin3, Lystra P Hayden4, Khanh Lai5, Jonathan Levin4,6, Winston M Manimtim7, Paul E Moore3, Catherine A Sheils4, Michael C Tracy8, Stamatia Alexiou9, Christopher D Baker10, A Ioana Cristea11, Julie L Fierro9, Lawrence M Rhein12, Natalie Villafranco13, Leif D Nelin14, Sharon A McGrath-Morrow9.   

Abstract

INTRODUCTION: Bronchopulmonary dysplasia (BPD) is a common respiratory sequelae of preterm birth, for which longitudinal outpatient data are limited. Our objective was to describe a geographically diverse outpatient cohort of former preterm infants followed in BPD-disease specific clinics.
METHODS: Seven BPD specialty clinics contributed data using standardized instruments to this retrospective cohort study. Inclusion criteria included preterm birth (<37 weeks) and respiratory symptoms or needs requiring outpatient follow-up.
RESULTS: A total of 413 preterm infants and children were recruited (mean age: 2.4 ± 2.7 years) with a mean gestational age of 27.0 ± 2.8 weeks and a mean birthweight of 951 ± 429 grams of whom 63.7% had severe BPD. Total, 51.1% of subjects were nonwhite. Severe BPD was not associated with greater utilization of acute care/therapies compared to non-severe counterparts. Of children with severe BPD, differences in percentage of those on any home respiratory support (p = .001), home positive pressure ventilation (p = .003), diuretics (p < .001), inhaled corticosteroids (p < .001), and pulmonary vasodilators (p < .001) were found between centers, however no differences in acute care use were observed. DISCUSSION: This examination of a multicenter collaborative registry of children born prematurely with respiratory disease demonstrates a diversity of management strategies among geographically distinct tertiary care BPD centers in the United States. This study reveals that the majority of children followed in these clinics were nonwhite and that neither variation in management nor severity of BPD at 36 weeks influenced outpatient acute care utilization. These findings suggest that post-neonatal intensive care unit factors and follow-up may modify respiratory outcomes in BPD, possibly independently of severity.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  bronchopulmonary dysplasia; chronic lung disease; outpatient; prematurity

Mesh:

Year:  2021        PMID: 33713587      PMCID: PMC8137590          DOI: 10.1002/ppul.25332

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  17 in total

1.  Bronchopulmonary dysplasia.

Authors:  A H Jobe; E Bancalari
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

2.  Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Authors:  Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

3.  Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia.

Authors:  Steven H Abman; Joseph M Collaco; Edward G Shepherd; Martin Keszler; Milenka Cuevas-Guaman; Stephen E Welty; William E Truog; Sharon A McGrath-Morrow; Paul E Moore; Lawrence M Rhein; Haresh Kirpalani; Huayan Zhang; Linda L Gratny; Susan K Lynch; Jennifer Curtiss; Barbara S Stonestreet; Robin L McKinney; Kevin C Dysart; Jason Gien; Christopher D Baker; Pamela K Donohue; Eric Austin; Candice Fike; Leif D Nelin
Journal:  J Pediatr       Date:  2016-11-28       Impact factor: 4.406

4.  Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia.

Authors:  Milenka Cuevas Guaman; Jason Gien; Christopher D Baker; Huayan Zhang; Eric D Austin; Joseph M Collaco
Journal:  Am J Perinatol       Date:  2015-03-04       Impact factor: 1.862

5.  An interdisciplinary bronchopulmonary dysplasia program is associated with improved neurodevelopmental outcomes and fewer rehospitalizations.

Authors:  E G Shepherd; A M Knupp; S E Welty; K M Susey; W P Gardner; A L Gest
Journal:  J Perinatol       Date:  2011-05-05       Impact factor: 2.521

6.  Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia.

Authors:  Vincent C Smith; John A F Zupancic; Marie C McCormick; Lisa A Croen; John Greene; Gabriel J Escobar; Douglas K Richardson
Journal:  J Pediatr       Date:  2004-06       Impact factor: 4.406

7.  Lung Function of Adults Born at Very Low Birth Weight.

Authors:  Jun Yang; Rachel A Kingsford; John Horwood; Michael J Epton; Maureen P Swanney; Josh Stanton; Brian A Darlow
Journal:  Pediatrics       Date:  2020-01-03       Impact factor: 7.124

8.  Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review.

Authors:  Csaba Siffel; Kristin D Kistler; Juliana F M Lewis; Sujata P Sarda
Journal:  J Matern Fetal Neonatal Med       Date:  2019-08-09

9.  Need for an International Consensus on the Definition of Bronchopulmonary Dysplasia.

Authors:  Tetsuya Isayama; Prakesh S Shah
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

10.  Diagnostic Classification of Bronchopulmonary Dysplasia: A Compromise between Defining Lung Disease versus Long-Term Outcome Prediction.

Authors:  Eduardo Bancalari; Nelson Claure; Deepak Jain
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

View more
  2 in total

1.  Insurance coverage and respiratory morbidities in bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Michael C Tracy; Catherine A Sheils; Jessica L Rice; Lawrence M Rhein; Leif D Nelin; Paul E Moore; Winston M Manimtim; Jonathan C Levin; Khanh Lai; Lystra P Hayden; Julie L Fierro; Eric D Austin; Stamatia Alexiou; Amit Agarwal; Natalie Villafranco; Roopa Siddaiah; Antonia P Popova; Ioana A Cristea; Christopher D Baker; Manvi Bansal; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2022-04-26

Review 2.  Influences of environmental exposures on preterm lung disease.

Authors:  Joseph M Collaco; Brianna C Aoyama; Jessica L Rice; Sharon A McGrath-Morrow
Journal:  Expert Rev Respir Med       Date:  2021-06-17       Impact factor: 3.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.